Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386178 · ClinicalTrials.gov registry record · Phase 1
Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00386178 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 16 participants.
The verdict
NCT00386178, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Gamma tocopherol (gt) is a naturally occurring form of vitamin E that is found in many foods, and is also commercially available as a vitamin supplement. The purpose of this Phase 1 research study is to see if two doses of gt, 600mg and 1200mg, are safe (do not cause gastrointestinal distress or other problems), and can cause changes in your blood levels of gt and other antioxidants. This study will also examine if there is a difference in response between asthmatic and non-asthmatic adults when taking the same dose of gt. Phase 1 research studies like this one are not intended to be a treatment, but are a scientific investigation.
Interventions
- DRUG Vitamin E supplement rich in gamma tocopherol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386178
The ClinicalTrials.gov registry entry for NCT00386178 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin E supplement rich in gamma tocopherol is the first listed.
NCT00386178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386178 about?
NCT00386178 is a clinical study titled "Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma". Gamma tocopherol (gt) is a naturally occurring form of vitamin E that is found in many foods, and is also commercially available as a vitamin supplement. The purpose of this Phase 1 research study is to see if two doses of gt, 600mg and 1200mg, are safe (do not cause gastrointestinal distress or oth...
What is the current status of trial NCT00386178?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2006-10. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00386178?
The interventions under investigation include: Vitamin E supplement rich in gamma tocopherol (DRUG).
Who is sponsoring clinical trial NCT00386178?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.